Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases

Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases

Background: Cardiometabolic morbidity and medications, specifically Angiotensin Converting Enzyme inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs), have been linked with adverse outcomes from coronavirus disease 2019 (COVID-19). This study aims to investigate, factors associated with COVID...

Description complète

Détails bibliographiques
Auteurs principaux: Zahra Raisi-Estabragh, Celeste McCracken, Maddalena Ardissino, Mae S. Bethell, Jackie Cooper, Cyrus Cooper, Nicholas C. Harvey, Steffen E. Petersen
Format: Article
Langue:English
Publié: Frontiers Media S.A. 2020-07-01
Collection:Frontiers in Cardiovascular Medicine
Sujets:
coronavirus disease 2019
UK Biobank
ethnicity
sex
obesity
cardiometabolic disease
Accès en ligne:https://www.frontiersin.org/article/10.3389/fcvm.2020.00138/full

Internet

https://www.frontiersin.org/article/10.3389/fcvm.2020.00138/full

Documents similaires